# Bioavailability of Medium Chain Triglycerides (MCTs) in Comatose Patients With Acute Brain Injury (ABI)

> **NCT02716532** · NA · COMPLETED · sponsor: **Société des Produits Nestlé (SPN)** · enrollment: 17 (actual)

## Conditions studied

- Injuries, Acute Brain
- Severe Trauma Brain Injury (sTBI)
- Subarachnoid Hemorrhage, Aneurysmal

## Interventions

- **DIETARY_SUPPLEMENT:** Peptamen AF

## Key facts

- **NCT ID:** NCT02716532
- **Lead sponsor:** Société des Produits Nestlé (SPN)
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04
- **Primary completion:** 2017-05-17
- **Final completion:** 2017-11-15
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2018-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02716532

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02716532, "Bioavailability of Medium Chain Triglycerides (MCTs) in Comatose Patients With Acute Brain Injury (ABI)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02716532. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*